Early cholecystectomy for patients with acute cholecystitis may not be possible in some clinical settings. Percutaneous gallbladder aspiration (PGBA) offers an alternative approach, but the benefits and risks of this procedure are unclear. We synthesized data on the outcomes of PGBA in acute cholecystitis patients using data sources from online databases, including MEDLINE and EMBASE, and bibliographies of included studies from January 2000 through December 2015. Two reviewers independently reviewed and critiqued the quality of each study. Seven eligible studies met our criteria. The success rates in single PGBA and repetitive PGBA (2-4 times) were 50% to 93% and 76% to 96%, respectively. Complication rates were 0% to 8% and were unrelated to the size of needle gauge used for aspiration and the number of aspirations. Salvage percutaneous cholecystostomy (PC) and urgent surgery were required in 0% to 43% of patients and 0% to 4% of patients, respectively. Two studies with antibiotic instillation had clinical success rates of 95% and 96%. In conclusion, repetitive PGBA combined with antibiotic instillation and salvage PC are useful alternatives to early cholecystectomy in patients with acute cholecystitis.
A cute cholecystitis is a common cause of acute abdominal pain. Up to 90% of these cases have calculous cholecystitis, which is caused by obstruction of the cystic duct or the neck of the gallbladder by gallstones ( 1 ) . Acalculous cholecystitis has a multifactorial pathogenesis, including bile stasis and/or ischemia of gallbladder, and occurs in 0.2% to 0.4% of all critically ill patients ( 2 ) . Th e standard management approach for acute cholecystitis is an early cholecystectomy ( 2 ). However, some patients in both the calculous and acalculous cholecystitis groups are high-risk surgical candidates because of comorbid medical conditions or presentations with severe sepsis or septic shock. Percutaneous cholecystostomy (PC) is frequently used in these patients and has a relatively high technical and clinical success rate ( 3, 4 ) . Percutaneous gallbladder aspiration (PGBA) is an alternative nonsurgical gallbladder drainage method used in some patients. It is a minimally invasive procedure that can be performed at the bedside under ultrasound guidance with a 14-to 21-gauge needle used for puncture ( 1, 5 ) . Drainage of bile improves the overall condition of patients by decompressing the gallbladder and reducing edema and infl ammation of the gallbladder wall and reduces the possibility of secondary 
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Supannee Rassameehiran , MD, Pakpoom Tantrachoti , MD, and Kenneth Nugent , MD infection of the gallbladder (3) (4) (5) (6) (7) (8) (9) (10) (11) . Several studies have been published on the outcomes and complications associated with PGBA, but the number of patients in these studies is typically small. We reviewed recent reports on the effi cacy of PGBA to provide a better overview of this procedure and its potential role in critically ill patients with acute cholecystitis.
METHODS
We searched MEDLINE and EMBASE from January 2000 through December 2015 using "percutaneous gallbladder aspiration" as a search term. We screened all articles and reviewed the reference lists from each included article and relevant review articles. Two independent reviewers (S.R. and P.T.) performed article selection, data extraction, and assessment of the risk of bias. Disagreements were resolved through consensus. Studies were included if they 1) were reported in English, 2) provided adequate data, and 3) were either a controlled clinical study or an observational study that assessed the outcomes of PGBA on acute cholecystitis, including clinical success rates on single aspiration and repetitive aspiration and complications. We excluded studies with <10 patients. If multiple updates of the same data were found, we used the most recent version for analysis.
From each study, we abstracted the study design, setting, patients' status and risk of surgery, inclusion and exclusion criteria, number of patients, number of gallbladder aspirations, and method of outcome determination. Two reviewers (S.R. and P.T.) independently assessed the quality of each trial by using a tool developed by the Cochrane Collaboration ( 12 ) . Each trial was given an overall summary assessment of low, unclear, or high risk of bias. We adapted existing tools to assess the quality of observational studies. Th e strength of evidence for outcomes was graded as high, moderate, low, or very low according to the approach of the GRADE working group ( 13 ) .
Th e methods used in these studies included single and repetitive PGBA with needle gauges ranging from 18 to 21 ( 3, 4, (6) (7) (8) (9) (10) . Th is limited our ability to make specifi c comparisons. Two studies used antibiotic instillation in addition to PGBA ( 7, 8 ) . We report the comparison of eff ectiveness and complications between PGBA and PC, the comparison of eff ectiveness and complications between single PGBA and repetitive PGBA, and other outcomes, including salvage PC, urgent surgery, and pain control. We did not perform a meta-analysis given the small number of heterogeneous studies.
RESULTS
Th e electronic and manual literature search identifi ed 84 total citations ( Figure 1 ) . We identifi ed 9 potentially relevant articles and analyzed 7 published articles, published as full papers, which met our inclusion criteria.
We identifi ed one randomized controlled study ( 4 ) and one observational study ( 3 ) that compared PGBA with PC and had an unclear risk of bias and low strength of evidence. Th e randomized controlled clinical study by Ito et al compared the eff ectiveness of PGBA using 21-gauge needles with PC using 6.5-or 7-French catheters ( 4 ) . Th is study recruited 58 patients with acute cholecystitis who did not respond to cefoperazonesulbactam or ceftazidime within 24 hours and excluded patients with pericholecystic liver abscess or severe coagulopathy and patients who did not give consent for the procedure. Th e technical success rates in PGBA and PC were 82% and 100%. All unsuccessful PGBAs were due to dense biliary sludge or pus. In the technically successful groups, a good clinical response was obtained in 90% of the PC group and in 61% of the PGBA group ( P < 0.05). Th irty percent of patients who did not have good clinical response after PGBA underwent PC. No major complications were reported in either group.
Chopra et al compared the eff ectiveness of PGBA using 18-gauge needles with PC using 6-to 10-French catheters ( 3 ). Th ey retrospectively identifi ed 53 non-critically ill patients with acute cholecystitis and a high risk for surgery who underwent either PGBA or PC. Th e technical success rates in PGBA and PC were 97% and 95%, respectively. Unsuccessful PGBAs were due to biliary sludge. In the technically successful groups, good clinical responses were obtained in 90% of the PC group and in 77% of the PGBA group. Ninety percent of patients who did not have good clinical response after PGBA underwent PC.
No signifi cant diff erence in clinical response was seen between the two groups treated with these two approaches ( P > 0.6). No complications related to PGBA were reported. We identifi ed four observational studies with repetitive PGBA ( 7-10 )(304 patients), two observational studies with single PGBA ( 3, 6 ) , and one randomized controlled study with single PGBA ( 4 ) (126 patients) ( Table 1 ) . All observational studies had a low strength of evidence. Single PGBA had success rates of 50% to 93% and complication rates of 0% to 4%. Two single PGBA studies reported serious adverse events from gallbladder aspiration, which included intraabdominal hemorrhage, bile leakage, gallbladder hemorrhage, and peritonitis ( 8, 10 ) . Repetitive PGBA (2-4 times) was reported in four studies, including two that used antibiotic instillation, and had clinical success rates of 76% to 96% and complication rates of 0% to 3%. Th e two studies with antibiotic instillation had clinical success rates of 95% and 96% ( 7, 8 ) , and the other two stud-ies without antibiotic instillation had clinical success rates of 76% and 92% ( 9, 10 ). Repetitive PGBAs had success rates of 47% to 96% in patients who did not improve with a single PGBA (7) (8) (9) (10) .
Th ree studies reported results in high-risk surgical patients, as defi ned by the authors. Th e studies included 131 patients who underwent 106 successful PGBAs (81%); 18 required salvage PC. Th e complication rate was 0% ( 3, 6, 9 ) . One randomized controlled study and six observational studies reported that 0% to 43% of patients required salvage PC and 0% to 7% of patients required surgery, either due to lack of improvement of symptoms, patient preference, or procedure-related complications ( 3, 4, (6) (7) (8) (9) (10) . Two observational studies reported immediate pain control rates of 99% to 100% ( 9, 10 ).
We found insuffi cient data to determine recurrence rates in patients who were successfully treated with PGBA and decided not to have cholecystectomy due to their preference or underlying diseases. Only two studies in our review reported recurrent cholecystitis rates during follow-up periods ( 9, 10 ) . Two patients in the Haas study did not have cholecystectomy; one developed recurrent cholecystitis requiring PGBA and the other remained asymptomatic after 16-month follow-up. Out of the 22 patients in the study reported by Tazawa who did not have cholecystectomy, 2 patients developed recurrent cholecystitis at 4-month and 31-month follow-up.
DISCUSSION
Patients who develop acute cholecystitis but have lifethreatening clinical presentations or severe chronic medical disorders are candidates for percutaneous gallbladder drainage. Th e standard approach to this drainage is PC performed by an interventional radiologist. However, this approach has complications, including pneumothorax, hemorrhage, bile peritonitis, and patient discomfort secondary to the cholecystostomy tube. An alternate approach to gallbladder drainage is ultrasound-directed aspiration. Th is approach reduces the pressure in the gallbladder and, in turn, reduces ischemia and the associated infl ammatory response. One argument against this approach is that an infected focus needs continuous drainage until the patient has a chance to respond to antibiotics and medical management. However, the culture positivity rate for gallbladder aspirates ranges from 30% to 78%, with an average of 33% in four recent studies, and many patients with acute cholecystitis do not have a bacterial infection in their gallbladder ( 3, 4, 7, 10 ) . Consequently, it would seem that PGBA is an underutilized approach in the management of these patients. Our literature review suggests that this approach has good technical success, good clinical success, and a low complication rate. One approach to the management of these patients is outlined in Figure 2 . We identifi ed seven recent articles with 430 patients reporting results with PGBA. Th e overall success rate was 98%. Fortytwo patients (10%) required PC, fi ve patients (1%) required urgent surgery, and 10 patients (2%) had complications. Th ese studies indicate that PC had higher success rates than PGBA and that PGBA had lower complication rates. Patients in high-risk surgical categories did well and had no complications. We think that repetitive PGBA could produce higher clinical success rates than single PGBA without increasing the complication rate, but we could not determine whether increased volumes of aspirated bile from repetitive PGBA increased the clinical success rate based on the available studies. Two observational studies in this review found no statistically signifi cant diff erence between volumes of aspirated bile in the successful and unsuccessful groups after single PGBA ( 7, 8 ) . Two observational studies used larger needle gauges to improve the technical success rate when the bile was too thick to aspirate ( 6, 7 ) . We also suspect that antibiotic instillation after PGBA may increase the clinical success rate, but there were no trials comparing PGBA and antibiotic instillation with PGBA alone. We did not fi nd enough information to calculate recurrent rates of cholecystitis in patients who were successfully treated with PGBA or PC and decided not to have cholecystectomy. Th erefore, the role of PGBA as defi nitive treatment for acute cholecystitis remains unclear.
Our review has several methodological limitations within the evidence base. Most studies included in our review were observational studies, which had low-strength evidence and did not provide suffi cient data to conduct a meta-analysis. Substantial clinical heterogeneity precluded precise summary estimates.
